Oryx International Growth Fund Ld
04 October 2007
4 October 2007
For Immediate Release
Oryx International Growth Fund Limited ('Oryx' or the 'Company')
Cancellation of C Shares
The Company announces that 2,542,376 C shares of 50 pence each ('C Shares') held
by Baltimore Capital plc, a wholly owned subsidiary of Oryx, have been
cancelled.
In addition, Oryx has also received 224,799 C Shares following the winding up of
Lionheart USA MicroCorp in which it was interested. These C Shares have also
been cancelled.
Accordingly, the Company's issued share capital now consists of the following:
16,252,774 ordinary shares of 50 pence each with voting rights
24,799,646 C Shares with voting rights
Therefore, the total number of voting rights in the Company is 41,052,420.
The above figure of 41,052,420 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in the Company under the FSA's
Disclosure and Transparency Rules.
Enquiries
Sara Radford/Jean McMillan
BNP Paribas Fund Services (Guernsey) Limited
Tel: + 44 (0)1481 743 004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.